# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-23-030386
Filing Date
2023-08-28
Accepted
2023-08-28 17:13:30
Documents
32
Period of Report
2023-08-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 37574
2 |  | ex99-1.htm | EX-99.1 | 15258
3 |  | ex99-1_001.jpg | GRAPHIC | 439021
4 |  | ex99-1_002.jpg | GRAPHIC | 385698
5 |  | ex99-1_003.jpg | GRAPHIC | 499119
6 |  | ex99-1_004.jpg | GRAPHIC | 334130
7 |  | ex99-1_005.jpg | GRAPHIC | 350698
8 |  | ex99-1_006.jpg | GRAPHIC | 377093
9 |  | ex99-1_007.jpg | GRAPHIC | 398131
10 |  | ex99-1_008.jpg | GRAPHIC | 241414
11 |  | ex99-1_009.jpg | GRAPHIC | 340532
12 |  | ex99-1_010.jpg | GRAPHIC | 354751
13 |  | ex99-1_011.jpg | GRAPHIC | 388149
14 |  | ex99-1_012.jpg | GRAPHIC | 322437
15 |  | ex99-1_013.jpg | GRAPHIC | 335414
16 |  | ex99-1_014.jpg | GRAPHIC | 394022
17 |  | ex99-1_015.jpg | GRAPHIC | 359276
18 |  | ex99-1_016.jpg | GRAPHIC | 308638
19 |  | ex99-1_017.jpg | GRAPHIC | 298418
20 |  | ex99-1_018.jpg | GRAPHIC | 432768
21 |  | ex99-1_019.jpg | GRAPHIC | 360015
| Complete submission text file | 0001493152-23-030386.txt |  | 9761189

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
22 | XBRL SCHEMA FILE | envb-20230828.xsd | EX-101.SCH | 3012
23 | XBRL LABEL FILE | envb-20230828_lab.xml | EX-101.LAB | 34240
24 | XBRL PRESENTATION FILE | envb-20230828_pre.xml | EX-101.PRE | 22357
26 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3443

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231217104
SIC: 2834 Pharmaceutical Preparations